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Recently reported decameric vanadate (V10) high aﬃnity binding site in myosin S1, suggests that it can be used as a tool in the
muscle contraction regulation. In the present article, it is shown that V10 species induces myosin S1 cleavage, upon irradiation, at the
23 and 74 kDa sites, the latter being prevented by actin and the former blocked by the presence of ATP. Identical cleavage patterns
were found for meta- and decavanadate solutions, indicating that V10 and tetrameric vanadate (V4) have the same binding sites in
myosin S1. Concentrations as low as 50 lM decavanadate (5 lM V10 species) induces 30% of protein cleavage, whereas 500 lM
metavanadate is needed to attain the same extent of cleavage. After irradiation, V10 species is rapidly decomposed, upon protein
addition, forming vanadyl (V4+) species during the process. It was also observed by NMR line broadening experiments that, V10
competes with V4 for the myosin S1 binding sites, having a higher aﬃnity. In addition, V4 interaction with myosin S1 is highly
aﬀected by the products release during ATP hydrolysis in the presence or absence of actin, whereas V10 appears to be aﬀected at
a much lower extent. From these results it is proposed that the binding of vanadate oligomers to myosin S1 at the phosphate loop
(23 kDa site) is probably the cause of the actin stimulated myosin ATPase inhibition by the prevention of ATP/ADP exchange, and
that this interaction is favoured for higher vanadate anions, such as V10.
 2004 Elsevier Inc. All rights reserved.
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Interest in the interaction of vanadate oxoanions with
biological systems has increased gradually since it was
demonstrated to have a variety of physiological eﬀects
acting either as a phosphate analogue in the monomeric
form ðH2VO4 Þ [1] or through oligomeric vanadate spe-
cies. Although it is often disregarded which of the oxo-
vanadates is the active species, most of the studies are
conducted at such low concentrations that the major
species in solution is the monomer. Among the oligo-0162-0134/$ - see front matter  2004 Elsevier Inc. All rights reserved.
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E-mail address: ttiago@ualg.pt (T. Tiago).meric species, probably the most interesting in biochem-
ical terms is the decamer ðV10O628 Þ, although it has been
reported that dimeric ðH3V2O7 Þ and cyclic tetrameric
ðV4O412 Þ forms may also inﬂuence the activity of several
enzymes [2,3]. Vanadate has also proved to be a valuable
tool to trap Mg2+ nucleotides in the catalytic site of
ATPases, particularly for mapping the active site of
myosin.
Myosin is the major muscle ATPase, which along with
actin converts the chemical energy of ATP hydrolysis into
mechanical work [4,5]. Vanadate inhibits myosin ATPase
activity through the formation, in the absence of actin, of
a long-lived complex withMgADP that is believed to mi-
mic the transition state of myosin**-ADP-Pi [6]. In the
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105 compared to that of myosin.ADP.V1 alone (5 · 106
s1), and consequently the inhibition is reverted [7]. Nev-
ertheless, it has been described that as long as excess Vi is
present (denoting a mixture of monomeric and polymeric
vanadate ions), the formation of the myosin.ADP.V1
complex is favoured even with the ‘‘destabilizing’’ inﬂu-
ence of actin [8,9]. Indeed, recently it was demonstrated
that the decameric vanadate (V10) inhibits the actin-stim-
ulated myosin ATPase activity, noncompetitively with
actin or with ATP upon interaction with a high-aﬃnity
binding site in myosin subfragment-1 (S1) [10]. In the
work described by Tiago et al. [10], the interaction of
V10 with myosin S1 was monitored using ﬂuorescently la-
belled S1 atCys-707 (SH1) andCys-697 (SH2), and the re-
sults pointed out that the binding of V10 to myosin is very
close to Cys-697. The ﬂexible loop between Cys-707 and
Cys-697 is believed to act as an energy transduction ele-
ment through which intersite communication between
ATP and actin binding sites is transmitted [11], and there-
fore could be related to the mechanism by which V10 (and
probably other vanadate oligomers) impairs the actin-
stimulated myosin ATPase activity. Moreover, it was
found that V10 binding is competitive with the c-phos-
phate modiﬁed nucleotide analogue, AP5A [10]. The
c-phosphate of ATP lies adjacent to Ser-180 and Ser-
243, two residues demonstrated to be photomodiﬁed by
tetrameric vanadate ðV4O412 Þ upon UV irradiation [12].
On this basis, it was suggested that V10 binds to the phos-
phate loop (amino acids 178–185), that forms part of the
consensus ATP binding site onmyosin, aﬀecting the actin
stimulated myosin ATPase activity. However, the analy-
sis supporting this hypothesis has not yet been reported,
as the residues implicated in V10 interaction with myosin
were not clearly identiﬁed. Moreover, it is still unknown
whether the other vanadate oligomers, particularly the
tetrameric vanadate, inhibit the actin stimulated myosin
ATPase activity through the same mechanism as V10.
Thus, in the present study, we further explore the mode
of action of decameric vanadate (V10) on myosin, by ana-
lysing the following aspects: (i) V10 binding sites on myo-
sin by showing unambiguously the residues undergoing
photo-cleavage due to the presence of decameric vana-
date; (ii) competition between decameric vanadate and
other vanadate oligomers for the binding sites on myosin
under the inﬂuence of natural ligands, suchas actin and/or
ATP, as analysed by 51V NMR spectroscopy.2. Materials and methods
2.1. Protein preparation
Myosin was prepared from leg and dorsal white rab-
bit skeletal muscle, as previously described by Pires et al.
[13]. The isolated myosin was then digested with a-chymotrypsin to obtain subfragment-1 (S1) according
to Margossian and Lowey [14]. F-actin was prepared
from acetone powder of rabbit skeletal muscle by the
method of Pardee and Spudich [15]. The complexes
S1  ADP  VO34 and S1  ADP  AlF4 for the pho-
tocleavage experiments were prepared according to
Werber et al. [16]. Brieﬂy, S1 previously dialyzed against
60 mM KCl, 25 mM Hepes (4-(2-hydroxyethyl)-1-piper-
azine ethane sulfonic acid), pH 7.9 was incubated at 25
C for 5 min with 1 mM MgCl2, 0.2 mM ADP and, for
AlF4 with 5 mM NaF. Then, metavanadate solution
(for VO34 ) or AlCl3 (for AlF

4 ) was added to a ﬁnal con-
centration of 0.2 mM and the incubation was continued
for 90 min at 25 C. Finally, the samples were passed
through a PD-10 column (Pharmacia) in order to re-
move excess of nucleotide analogues. Myosin and Sub-
fragment-1 concentrations were determined by the
Bradford assay using bovine serum albumin as a stand-
ard, while G-actin concentration was measured spectro-
photometrically by using an extinction coeﬃcient of
e1%290 ¼ 11:5 cm1. Molecular weights of 500, 115, and
42 kDa were considered for myosin, S1, and actin,
respectively.
2.2. Vanadate solutions
Metavanadate solution (50 mM, pH 6.0–7.0) was pre-
pared from ammonium metavanadate (NH4VO3) pur-
chased from Riedel-de-Haen. Decavanadate solution
was prepared in a manner that maximized the propor-
tion of vanadate that was present as the decamer, by
adjusting the pH of the metavanadate solution to 4.0
[17]. The presence of decameric vanadate species was re-
vealed by a characteristic orange colour. Both solutions
were kept at 4 C.
2.3. Photocleavage studies
Photoirradiation was carried out in a reaction mix-
ture containing 4.5 lM myosin S1, 25 mM KCl, 2.5
mM MgCl2, 25 mM Hepes, pH 7.0, in the presence or
absence of 5–1000 lM vanadate solutions, 5 mM ATP
and 10 lM actin. The mixture (2 ml) in quartz cell
and cooled on a water bath was irradiated with a 400
W medium-pressure Hg lamp (Applied Photophysics)
at an average distance of 5 cm. Radiation below 300
nm was removed (in order to prevent protein degrada-
tion by UV irradiation) by using a CuSO4 solution, hav-
ing a peak of transmittance at 365 nm. The sample was
then subjected to electrophoretic analysis on a 12% so-
dium dodecyl sulfate (SDS)–polyacrylamide gel.
2.4. NMR measurements
1D 51V NMR spectroscopy measurements were per-
formed on a Bruker AM-400 MHz spectrometer at
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probe. Spectra were acquired at 22 C using 0.5 ml of
samples containing 10% D2O, under the following con-
ditions: 90 pulse angle, spectral width 23923 Hz, acqui-
sition time 0.086 s, number of transients 10 000 and
relaxation delay 0.01 s. 51V NMR chemical shifts are re-
ported relative to an external reference of VOCl3 (0
ppm). NMR spectra of metavanadate (2 mM) and poly-
vanadate (2 mM metavanadate + 5 mM decavanadate)
solutions were obtained in a reaction medium contain-
ing 25 mM KCl, 2.5 mM MgCl2, 25 mM Hepes, pH
7.0 in the absence and presence of myosin S1, actin or
ATP as desired. The 51V NMR line widths of the several
free and bound vanadate resonances represent the
widths at half-height after subtraction of 20 Hz used
in line broadening. The concentrations of each vanadate
species Vx were calculated from the fractions of the total
integrated areas using the following equation:
[Vx] = (Ax/At) · ([Vt]/n), where Ax corresponds to the
area measured for the x vanadate species with n aggrega-
tion number (number of vanadium atoms), At the sum
of measured areas, and [Vt] the total vanadate concen-
tration, as described elsewhere [17].Fig. 1. SDS–PAGE analysis of the Vi-dependent photocleavage of
myosin S1 (4.5 lM) in a medium containing 25 mM KCl, 2.5 mM
MgCl2, 25 mM Hepes, pH 7.0. Samples were irradiated for 20 min. as
stated in Materials and Methods section and then run on a 12%
acrylamide gel. (Panel A) SDS gel electrophoresis pattern of S1
following irradiation in the absence (a) and presence of 10 lMV10 (100
lM total vanadium added as decavanadate) with no additions (b); or
with 5 mM ATP (c); 10 lM F-actin (d); and 5 mM ATP + 10 lM F-
actin (e). Control S1–ADP–V1 in the absence (f) and presence of 10
lM V10 (g). Control S1–ADP–AlF4 in the absence (h) and presence of
10 lM V10 (i). (Panel B) Formation of the 74 kDa fragment estimated
from the densitometry of the peptide bands upon increasing vanadate
concentration up to 500 lM for metavanadate (squares) and
decavanadate (circles) solutions. HC, LC1 and LC3 stands for S1
heavy chain, myosin light chain 1 and myosin light chain 3,
respectively.3. Results and discussion
Vanadate is photochemically active and irradiation of
protein-bound vanadate species with UV light results in
polypeptide photo-oxidation and cleavage making
possible the identiﬁcation of vanadate binding sites
[18–21]. In the present work, a series of decavanadate-
dependent photocleavage experiments were carried out
in order to clearly identify decameric vanadate (V10)
binding sites on myosin. The electrophoretic patterns
were analyzed and the results are summarized in
Fig. 1. It was observed that irradiation of myosin S1
(4.5 lM) for 20 min, in the presence of 100 lM deca-
vanadate (10 lM V10 species), caused the cleavage of
the S1 95 kDa heavy chain at the 23 kDa- and, to a
much lower extent, at the 74 kDa-sites, producing the
23 and 21 kDa cleavage products, respectively (Fig.
1(A), lane b). An additional product of 51 kDa also ap-
pears, likely derived from the further cleavage of the 74
kDa fragment. In presence of 2 mM ATP, the cleavage
at the 23 kDa is inhibited leaving only the 74 kDa site
available to photocleavage as can be seen from the
appearance of a tenuous 21 kDa band (Fig. 1(A), lane
c). The same observation was veriﬁed in the presence
of S1-ADP-V1 and S1-ADP-AlF4 (Fig. 1(A), lanes g
and i, respectively), two complexes known to mimic
the intermediate activated myosin**-ADP-Pi state
[16,22,23]. In presence of actin (10 lM), the cleavage
at the 74 kDa site was totally protected while enhancing
the cleavage at the 23 kDa site (Fig. 1(A), lane d). How-
ever, when ATP is added in the presence of actin, the 23kDa site is no longer susceptible to photocleavage by
decavanadate (Fig. 1(A), lane e).
The electrophoretic patterns found for the decavana-
date-dependent myosin S1 photocleavage in the present
work are identical to the ones previously reported in the
presence of metavanadate concentrations higher than
0.2 mM. Myosin S1 was shown to be photoirradiated
by near UV-light in the presence of vanadate at three
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[24]. The cleavages at the 23 and 31 kDa sites, which
were assigned to Ser-180 and Ser-243, respectively, are
located in the consensus ATP binding site [25,26] while
the 74 kDa site is near the Lys-rich 50/20 kDa junction
which is believed to participate in an actin binding site
[27]. Since 51V NMR studies have shown that the tetra-
meric vanadate binds most strongly to myosin [12] and
is favoured for vanadate concentrations higher than
0.2 mM, it was suggested that this species is the most
likely responsible for the cleavage products.
Given the rapid exchange rates between the labile
oligovanadates (V1, V2, and V4) [2] it is not possible to
isolate a speciﬁc anion and consequently an equilibrium
mixture must be examined, which may complicate stud-
ies aimed to determine the eﬀect of a speciﬁc anion.
Although vanadate decamer is a less labile oligomer,
remaining relatively intact for studies of limited dura-
tion, in previous NMR studies it was shown that upon
dilution to the reaction medium (pH 7.0), the decavana-
date solution can contain approximately 10% of mono-
meric vanadate [17]. To ascertain whether the
monomeric vanadate (V1) added with decavanadate
solutions, or eventually formed during irradiation due
to decameric species decomposition, can account for
the electrophoretic patterns observed in Fig. 1(A), we
have carried out photocleavage reactions with 4.5 lM
S1 over a wide range of meta- and deca-vanadate con-Fig. 2. UV–Vis diﬀerential spectra from 240–700 nm of 250 lM decavanadate
Hepes, pH 7.0: (a) after diﬀerent times of irradiation (0–20 min) in presen
concentrations (0, 0.45, 0.9 and 4.5 lM) at a ﬁxed time of irradiation (20 mcentrations (5–1000 lM total vanadium). The formation
of the 74 kDa fragment, as estimated from the densitom-
etry of this peptide band, was followed and the results
represented in Fig. 1(B). For decavanadate, cleavage
starts to occur at vanadate concentrations as low as 5
lM (0.5 lM V10 species) increasing sharply up to 50
lM total vanadium (5 lM V10 species) and reaching
30% of protein cleavage. For metavanadate, cleavage
at concentrations lower than 100 lM (containing mainly
monomeric species) is modest and, only at concentra-
tions favouring di- and tetra-meric vanadate species
(500 lM), the extent of cleavage is comparable to the
maximum decavanadate cleavage, ruling out the contri-
bution of the monomeric vanadate to protein cleavage
and indicating the vanadate oligomers as the photoac-
tive species. However, for higher vanadate concentra-
tions (1 mM), it was observed that while for
decavanadate the extent of cleavage remains essentially
constant never exceeding 30%, for metavanadate it ex-
ceeds 45% (results not shown).
The lower extent of cleavage found for decavanadate
when compared to metavanadate solutions, at higher
vanadate concentrations (1 mM), prompted us to mon-
itor, by UV/VIS spectroscopy, the spectral changes in
the 240–700 nm region of decavanadate solutions before
and after exposure to irradiation, in order to examine
the consequence of irradiation on V10 species stability.
The results are presented in Fig. 2, as the diﬀerencesolution in a medium containing 25 mMKCl, 2.5 mMMgCl2, 25 mM
ce of 4.5 lM myosin S1; (b) in the presence of diﬀerent myosin S1
in).
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decrease of an absorption band centred at 390 nm (char-
acteristic of decameric vanadate), corresponding to a de-
crease of the decamer concentration. In the presence of
4.5 lM S1, after 1 min irradiation, the absorption band
at 390 nm of the decavanadate solution (250 lM) de-
creases almost 38%, and it reaches 80% after 20 min,
with the concomitant increase of a broad band near
700 nm, indicative of vanadyl (V4+ species) formation
during the process (Fig. 2(a)). Furthermore, the decrease
of the decameric absorption band occurs only in the
presence of myosin S1, with slight changes for S1 con-
centrations between 0.45 and 4.5 lM, pointing out that
V10 decomposition is promoted upon protein irradiation
(Fig. 2(b)). In fact, it is known that the mechanism of
vanadate-promoted photocleavage reaction on myosin
involves addition of molecular oxygen to a stabilized
seryl radical generated by a light-catalyzed vanadate
(V5+) reduction to vanadyl (V4+) [28]. It was also re-
cently shown that V5+ of V10 is more easily reduced in
comparison to V1, V2 and V4 present in metavanadate
solutions [29]. These observations could account for
the rapid decomposition of the decameric vanadate
(V10), upon protein addition, into vandyl species after
a short irradiation time as described above (Fig. 2), as
well as for the higher cleavage eﬃciency of decavanadate
for extremely low vanadate concentrations when com-
pared to metavanadate (Fig. 1(B)).
Collectively, the results in Figs. 1 and 2 demonstrate
that, besides tetrameric vanadate (V4), also decameric
vanadate (V10) is photoactive and apparently is a better
substrate for the myosin S1 photocleavage reaction than
the former species. In addition, the identical cleavage
patterns found for deca- and meta-vanadate solutions
suggests that V10 and V4 have the same binding sites
in myosin S1. On this basis, we further evaluated theFig. 3. 51V NMR spectra of 2.0 mM nominal metavanadate solution in the a
lM S1 + 30 lM F-actin (D,H) with (Right panel) or without (Left panel) 2
KCl, 2.5 mM MgCl2, 25 mM Hepes, pH 7.0 at 22 C. V1, V2 and V4 are ref
respectively.competition between decameric vanadate and other
vanadate oligomers, particularly tetrameric vanadate,
for the myosin S1 binding sites. For that purpose, we
have monitored changes in the 51V NMR signals upon
protein addition to vanadate solutions containing both
species (V10 and V4) at several experimental conditions.
While it is possible, at pH 7.0, to obtain a decavana-
date stock solution containing exclusively decameric
species, only for metavanadate concentrations lower
than 200 lM, monomeric species is mainly present
[30,31]. As the vanadate concentration is raised, oligo-
meric forms start to be favoured. In the present NMR
experiments, a 2 mM metavanadate solution was used
containing approximately 766 lM monovanadate, 146
lM divanadate, and 236 lM cyclic tetravanadate calcu-
lated from the fractions of the total integrated areas of
the 51V NMR resonances, as stated in Materials and
Methods section, at 561.0, 574.6 and 578.8 ppm,
respectively (Fig. 3(A)). On the other hand, when a
decavanadate stock solution is diluted into the reaction
medium, decameric vanadate is partially converted into
monomeric vanadate [32]. The monomer contribution
increases with incubation time accompanied by the
appearance of di- and tetrameric vanadates. Since the
kinetics of dissociation of decameric vanadate is rela-
tively slow, we have used a mixed solution containing
2 mM-meta and 5 mM-decavanadate, referred as poly-
vanadate solution, in order to have both V4 and V10
species in the same solution. As can be observed in
Fig. 4(A), in addition to the resonances of the metavana-
date solution (Fig. 3(A)), the spectra presents three new
NMR signals at 515.5 (V10A), 499.2 (V10B) and
425.2 ppm (V10C) corresponding to the three diﬀerent
chemical environmental vanadate atoms in the deca-
meric vanadate molecule structure. In this solution, the
concentration of the vanadate oligomers is approxi-bsence (A,E) and presence of 30 lM S1 (B,F); 30 lM F-actin (C,G); 30
mM ATP. The spectra were collected in a medium containing 25 mM
erring to monomeric, dimeric and cyclic tetrameric forms of vanadate,
Fig. 4. 51V NMR spectra of 2.0 mM nominal metavanadate + 5.0 mM nominal decavanadate solutions in the absence (A,E) and presence of 30 lM
S1 (B,F); 30 lMF-actin (C,G); 30 lM S1 + 30 lMF-actin (D,H) with (Right panel) or without (Left panel) 2 mMATP. The spectra were collected in
a medium containing 25 mM KCl, 2.5 mM MgCl2, 25 mM Hepes, pH 7.0 at 22 C. V1, V2 and V4 are referring to monomeric, dimeric and cyclic
tetrameric forms of vanadate, respectively. V10A, V10B, and V10C correspond to the three chemical environmental diﬀerent vanadate atoms in the
decameric vanadate structure.
Table 1
Chemical shifts (d), line widths (Dm1/2), and broadening factor of the line widths (F) of monomeric (V1), dimeric (V2), and tetrameric (V4) forms of
vanadate present in 2 mM nominal metavanadate (META) solution in diﬀerent experimental conditions
Meta (2 mM )
V1 V2 V4
No protein (A)
d (ppm) 561.0 574.6 578.8
Dm1/2 (Hz) 75.2 150.3 75.2
30 lM S1 (B)
d (ppm)  561.2  574.6 579.1
Dm1/2 (Hz) 75.2 150.3 225.6
F (relative to A) (1.0) (1.0) (3.0)
30 lM F-actin (C)
d (ppm) 561.0  574.5 578.8
Dm1/2 (Hz) 75.2 150.3 75.2
F (relative to A) (1.0) (1.0) (1.0)
30 lM S1 + 30 lM F-actin (D)
d (ppm) 561.1 574.6 578.8
Dm1/2 (Hz) 112.8 225.6 376
F (relative to C) (1.5) (1.5) (5.0)
No protein + 2 mM ATP (E)
d (ppm)  561.0  574.5  578.9
Dm1/2 (Hz) 75.2 150.3 75.2
F (relative to A) (1.0) (1.0) (1.0)
3 lM S1 + 2 mM ATP (F)
d (ppm) 561.6 574.8 579.0
Dm1/2 (Hz) 90.2 150.3 150.3
F (relative to E) (1.2) (1.0) (2.0)
30 lM F-actin + 2 mM ATP (G)
d (ppm) 561.0 574.5 578.9
Dm1/2 (Hz) 75.2 150.3 75.2
F (relative to E) (1.0) (1.0) (1.0)
30 lM S1 + 30 lM F-actin + 2 mM ATP (H)
d (ppm) 562.0 574.8 578.8
Dm1/2 (Hz) 112.8 150.3 188.0
F (relative to G) (1.5) (1.0) (2.5)
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divanadate (V2), 219 lM for tetravanadate (V4) and
461 lM for decavanadate (V10).
51V NMR spectra of
meta- and poly-vanadate solutions were collected in
the presence or absence of myosin natural ligands such
as ATP and actin, and the relative order of vanadate sig-
nals line broadening upon protein addition (reﬂecting
the interaction of vanadate species with myosin S1)
was evaluated and presented in Tables 1 and 2 for meta-
vanadate and polyvanadate solutions, respectively. The
corresponding NMR spectra can be followed in Figs.
3 and 4. Myosin S1 (30 lM), selectively broadened by
a factor of ﬁve and decreased the intensity of V4 reso-
nance in the metavanadate solution with no eﬀects on
the mono- or di-vanadate signals (Table 1, Fig. 3(A)).
In the same way, V10 resonance in the polyvanadate
solution was selectively broadened, by a factor of three,
preventing any changes of the V4 or the other vanadate
NMR signals (Table 2, Fig. 4(B)). These results implied
a preferential binding of higher vanadate oligomers to
the protein and suggest either a competition between
decavanadate and tetravanadate for the same bindingTable 2
Chemical shifts (d), line widths (Dm1/2), and broadening factor of the line widt
(V10) forms of vanadate present in 2 mM nominal metavanadate (ME
experimental conditions
Meta (2 m
V1
No protein (A)
d (ppm) 561.1
Dm1/2 (Hz) 75.2
30 lM S1 (B)
d (ppm) 561.2
Dm1/2 (Hz) 75.2
F (relative to A) (1.0)
30 lM F-actin (C)
d (ppm) 561.1
Dm1/2 (Hz) 75.2
F (relative to A) (1.0)
30 lM S1 + 30 lM F-actin (D)
d (ppm) 561.3
Dm1/2 (Hz) 75.2
F (relative to C) (1.0)
No protein + 2 mM ATP (E)
d (ppm) 561.1
Dm1/2 (Hz) 75.2
F (relative to A) (1.0)
30 lM S1 + 2 mM ATP (F)
d (ppm) 561.3
Dm1/2 (Hz) 75.2
F (relative to E) (1.3)
30 lM F-actin + 2 mM ATP (G)
d (ppm) 561.1
Dm1/2 (Hz) 75.2
F (relative to E) (1.0)
30 lM S1 + 30 lM F-actin + 2 mM ATP (H)
d (ppm) 561.8
Dm1/2 (Hz) 150.3
F (relative to G) (1.0)site(s), in concordance with the photocleavage studies
described above, or a localized structural change caused
by decavanadate that prevents tetravanadate binding.
Addition of either F-actin (30 lM) or ATP (2 mM) to
myosin S1 free meta- and polyvanadate samples does
not induced signiﬁcant diﬀerences in the line widths
and chemical shifts of the vanadate resonances (Table
1, Fig. 3(C), (E) and Table 2, Fig. 4C, E for meta- and
poly-vanadate samples, respectively), indicating that
neither F-actin or ATP associate with any of the forms
of vanadate present in the reaction medium, in agree-
ment with previous reports [10,24]. Moreover, actin ap-
pears not to aﬀect the binding of either V4 or V10 to
myosin S1, as the increase in the line width broadening
of the NMR signals upon myosin S1 addition is similar
in the absence or presence of actin (Table 1, Fig. 3(D)
and Table 2, Fig. 4(D) for V4 and V10, respectively).
On the other hand, when ATP is added to the medium
containing myosin S1 either in the absence (Fig. 3(F))
or presence (Fig. 3(H)) of actin, V4 signal becomes nar-
row (broadening factor of 2) (Table 1) as shown previ-
ously by Ringel et al. [24] for myosin S1, in thehs (F) of monomeric (V1), dimeric (V2), tetrameric (V4), and decameric
TA) + 5 mM nominal decavanadate (DECA) solutions in diﬀerent
M) + Deca (5 mM)
V2 V4 V10
574.5 578.8 515.5
150.3 75.2 150.3
574.7 578.7 515.2
188.0 75.2 450.9
(1.2) (1.0) (3.0)
574.5 578.8 515.4
150.3 75.2 225.6
(1.0) (1.0) (1.5)
574.6 578.7 515.7
112.8 75.2 676.4
(1.0) (1.0) (3.0)
574.6 578.8 515.5
112.8 75.2 150.3
(0.8) (1.0) (1.0)
574.6 579.0 515.6
188.0 75.2 451.2
(1.3) (1.0) (3.0)
574.6 578.8 515.4
150.3 75.2 225.6
(1.3) (1.0) (1.5)
574.7 578.8 515.4
150.3 75.2 451.2
(1.0) (1.0) (2.0)
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the sarcoplasmic reticulum Ca2+-ATPase, which sug-
gests that tetravanadate is displaced from the protein
in presence of ATP either with or without actin. Contra-
rily to these observations, the presence of the substrate
upon protein addition seems not to signiﬁcantly aﬀect
the line width of V10 NMR signal in the absence, or to
much lower extent in the presence of actin as can be seen
from Fig. 4(F) and (H), respectively, and Table 2. When
interpreting this ﬁnding we can not exclude, however,
the fact that the line broadening of bound V10 is very
large and may be masking possible ATP eﬀects on V10
binding to myosin S1. In this regard, it may be that some
displacement of decavanadate occurs although in less
extent than tetravanadate. Moreover, it is known that
the rapid exchange between bound and free decavana-
date is likely to contribute to the disappearance of the
signal even in the presence of excess vanadate [2].
In the present article, we have determined unambigu-
ously the residues undergoing photocleavage on myosin
by the decameric vanadate (V10), demonstrating two
putative binding sites: (i) one of higher aﬃnity (23
kDa) located on the 178–185 sequence (loop-P) which
forms the consensus ATP binding site of myosin; and
(ii) another one of lower aﬃnity (74 kDa) from residues
627–646 (loop-2), which is part of the actin-binding
interface. These results came to conﬁrm the hypothesis
recently proposed by Tiago et al. [10] of the preference
V10 binding to the Walker A motif or P-loop on myosin
which forms part of the phosphate tube. Yount et al. [9]
have previously postulated that actin binding promotes
the movement of P-loop, containing Ser-181, which al-
lows Pi from ATP to leave via a ‘‘back-door’’ in the
50-kDa fragment while ADP is still bound at the active
site. It was also proposed by the same authors that in
ﬁbers, vanadate could enter the active site via the
‘‘back-door’’ to form the more stable MgADP.Vi.myo-
sin complex inducing muscle relaxation. However, this
is only possible if an excess vanadate is present which
is described to favour vanadate oligomerization. In fact,
it was shown that V10 binding produces non-competitive
inhibition of the actin-stimulated S1-ATPase activity
(Ki = 0.27 ± 0.05 lM), without causing dissociation of
the acto-S1 complex [10]. Altogether, these results sug-
gest that the replacement of the c-phosphate of ATP
by V10 at the phosphate loop, forming the V10-myosin-
ADP-Mg complex during ATP hydrolysis, will probably
block actin-stimulated S1-ATPase activity acting as a
‘‘back-door stop’’ by preventing ADP/ATP exchange.
Another important result is that V10 and V4 bind to
the same protein binding site(s), although its interac-
tions are diﬀerently modulated by the myosin natural
ligands (ATP and actin). While V4 is highly aﬀected by
the products release during ATP hydrolysis, V10 appears
to be aﬀected at a much lower extent, as shown by the
NMR line broadening experiments. In addition, V10has a greater aﬃnity for myosin binding sites than V4,
in the same way that, V4 has a greater aﬃnity than the
lower vanadate oligomers, which can be explained if
electrostatic forces play an important role in vanadate
interaction with myosin. In this sense, it is concluded
that besides V10, other vanadate oligomers may contrib-
ute to the inhibition of the actin-stimulated myosin AT-
Pase activity, through binding at the myosin phosphate
loop, although the protein aﬃnity is favoured for higher
vanadate anions such as V10.
Even if V10 is not likely to be present at signiﬁcant
concentrations under physiological conditions, it has re-
vealed to be a useful biochemical tool not only for the
description of the location and function of the phos-
phate binding sites on myosin, but also for the molecu-
lar interpretation of actomyosin interactions and
consequently for muscle contraction regulation.Acknowledgements
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